SEC Form 4 · accession 0001209191-18-036185
Pacira BioSciences, Inc. · PCRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J. Weiland
Officer — Chief Commercial Officer
Period of report
Jun 4, 2018
Accepted (ET)
Jun 6, 2018 · 8:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001396814
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jun 4, 2018 | S | 373 | $33.02 | D | 5,088 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
- F2Includes 339 and 258 shares of common stock acquired under the issuer's employee stock purchase plan in June 2017 and December 2017, respectively.